Table 2. Univariable and Multivariable Analysis for Unfavorable Functional Outcome at 3 Months (mRS, 3–6).
Unfavorable outcome(n = 2626) | Favorable outcome(n = 4449) | Univariable analysis | Multivariable analysis | |||
OR (95% CI) | P | *aOR (95% CI) | P | |||
Age, year | 72.8 (±11.6) | 64.4 (±12.8) | 1.06 (1.06–1.07) | <0.001 | 1.05 (1.04–1.06) | <0.001 |
Male | 1281 (48.8) | 2865 (64.4) | 0.53 (0.48–0.58) | <0.001 | 0.68 (0.55–0.85) | 0.001 |
Risk factor (%) | ||||||
Previous stroke | 824 (31.4) | 694 (15.6) | 2.47 (2.20–2.78) | <0.001 | 2.14 (1.68–2.73) | <0.001 |
Hypertension | 1941 (73.9) | 2985 (67.1) | 1.39 (1.25–1.55) | <0.001 | 0.93 (0.74–1.18) | 0.539 |
Diabetes | 989 (37.7) | 1390 (31.2) | 1.33 (1.20–1.47) | <0.001 | 1.12 (0.90–1.40) | 0.311 |
Hyperlipidemia | 850 (32.4) | 1484 (33.4) | 0.96 (0.86–1.06) | 0.394 | ||
Current Smoking | 511 (19.5) | 1364 (30.7) | 0.55 (0.49–0.61) | <0.001 | 1.10 (0.84–1.44) | 0.496 |
TIA presentation andStroke subtype, n (%) | ||||||
TIA presentation | 3 (0.1) | 32 (0.7) | 0.35 (0.11–1.15) | 0.084 | 0.01 (1.00–1.00) | 1.000 |
LAA | 1023 (39.0) | 1585 (35.6) | 2.41 (2.07–2.81) | <0.001 | 1.74 (1.30–2.32) | <0.001 |
SVO | 288 (11.0) | 1077 (24.2) | 1.0 (referent) | - | 1.0 (referent) | - |
CE | 685 (26.1) | 731 (16.4) | 3.50 (2.97–4.14) | <0.001 | 1.02 (0.72–1.45) | 0.898 |
SOE | 59 (2.2) | 117 (2.6) | 1.89 (1.34–2.65) | <0.001 | 4.37 (2.33–8.21) | <0.001 |
SUE | 568 (21.6) | 907 (20.4) | 2.34 (1.98–2.77) | <0.001 | 1.18 (0.84–1.64) | 0.345 |
NIHSS score at admission | ||||||
Mean (±SD) | 9.3 (±6.8) | 3.1 (±3.3) | 1.31 (1.29–1.33) | <0001 | 1.29 (1.25–1.32) | <0.001 |
Median (IQR) | 7 (10) | 2 (3) | <0.001 | |||
Prehospital delay (hour) | 7.7 (25.2) | 9.1 (±27.6) | 1.00 (1.00–1.00) | 0.005 | 1.00 (1.00–1.00) | 0.935 |
Onset to Needle time (min) | 115 (67) | 115 (62) | 0.906 | |||
Door to Needle time (min) | 45 (24) | 45 (22) | 0.366 | |||
IV rtPA | 282 (29.2) | 324 (23.4) | 1.35 (1.12–1.63) | 0.002 | 0.46 (0.34–0.61) | <0.001 |
Off-hour (vs. Work-hour) | 1291 (49.2) | 2182 (49.0) | 1.01 (0.91–1.11) | 0.924 | 0.89 (0.72–1.09) | 0.262 |
Abbreviations are presented in the previous table.
All the 7075 patients were included in the multivariable analysis.
*aOR: adjusted odds ratio.